ViaCogScreen: An Efficient, Valid, and Repeatable Screening Tool for Cognitive Performance Assessment of the Elderly

被引:0
作者
Schneider, Matthias [1 ]
Potthoff, Anna-Laura [1 ]
Pannicke, Lars [2 ]
von Arnim, Christine A. F. [3 ]
Jessen, Frank [4 ]
Helmstaedter, Christoph [5 ]
机构
[1] Univ Klinikum Bonn, Klin & Poliklin Neurochirurg, Bonn, Germany
[2] Viamed GmbH Med Consulting, Stuttgart, Germany
[3] Univ Med Gottingen, Abt Geriatrie, Gottingen, Germany
[4] Univ klinikum Koln, Klin & Poliklin Psychiat & Psychotherapie, Cologne, Germany
[5] Univ Klinikum Bonn, Klin & Poliklin Epileptol, Bonn, Germany
关键词
MCI; neuropsychology; computer-assisted screening; cognition; dementia; NEUROPSYCHOLOGICAL ASSESSMENT BATTERY; IMPAIRMENT; EPILEPSY; ACCURACY; IMPROVES;
D O I
10.1055/a-2276-3557
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Given the demographic change with an aging society in Germany, cognitive performance assessment of the elderly is of great importance. The Viacogscreen developed by us is a computer- and web-based brain performance screening for older adults that not only meets the criteria of a measurement instrument, but is also economical and repeatable. The test captures interlocking word list learning with delayed free recall and recognition, semantic word selection and fluidity, phonemic word fluidity and inverted number range, as well as incidental memory, resulting in a total of 17 performance parameters that provide a quick orientation (approximate test duration: 10-12 minutes) regarding the cognitive performance of a test subject. Three performance areas are depicted: executive functions, episodic and semantic memory. The test was standardized for 200 healthy test subjects in 6 different age groups (range: 50-85 years). For the first clinical validation, the test was used in the memory clinics in Bonn and Ulm, where 33 patients with MCI (mild cognitive impairment) and 42 patients with suspected Alzheimer's disease (VAD) were tested. A control group of 42 healthy people of approximately the same age served as the control group. With regard to the cognitive test procedure, all three groups showed significantly different results regarding the overall score (ANOVA F=73.9, p<0.001), executive functions (F=27.6 p<0.001) and semantic memory (F=54.4 p<0.001). Regarding episodic memory, both clinical groups differed significantly from the control group, but not from each other (F=48.7, p<0.001). The Viacogscreen thus produced very good results in its first validation in two memory clinics with regard to differentiation of VAD, and good results with regard to MCI. In addition to use in neurodegenerative diseases, the Viacogscreen is also suitable for other neurological and neuro-oncological diseases, as well as for use in large clinical studies since it enables electronic data collection.
引用
收藏
页数:11
相关论文
共 14 条
[1]   Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI) [J].
Arevalo-Rodriguez, Ingrid ;
Smailagic, Nadja ;
Roque-Figuls, Marta ;
Ciapponi, Agustin ;
Sanchez-Perez, Erick ;
Giannakou, Antri ;
Pedraza, Olga L. ;
Cosp, Xavier Bonfill ;
Cullum, Sarah .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (07)
[2]   NeuroCogFX -: A computer-based neuropsychological assessment battery for the follow-up examination of neurological patients [J].
Fliessbach, K. ;
Hoppe, C. ;
Schlegel, U. ;
Elger, C. E. ;
Helmstaedter, C. .
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2006, 74 (11) :643-650
[3]   Rapid detection of major depression in epilepsy: a multicentre study [J].
Gilliam, FG ;
Barry, JJ ;
Hermann, BP ;
Meador, KJ ;
Vahle, V ;
Kanner, AM .
LANCET NEUROLOGY, 2006, 5 (05) :399-405
[4]   Assessing Activities of Daily Living in Patients with Epilepsy [J].
Helmstaedter, C. ;
Droege, F. ;
Witt, J. -A. .
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2013, 81 (08) :452-458
[5]  
Helmstaedter C., 2001, Gottingen: Beltz Test
[6]  
Helmstaedter C, 2012, EpiTrack. Veranderungssensitives kognitives Skreening zur Qualitats- und Outcomekontrolle der medikamentosen Epilepsiebehandlung. 2te Auflage ed, V2nd
[7]  
Helmstaedter C., 2010, Neues Screeningverfahren zum Leistungsmonitoring-Neurowoche Mannheim
[8]   DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia [J].
Kalbe, E ;
Kessler, J ;
Calabrese, P ;
Smith, R ;
Passmore, AP ;
Brand, M ;
Bullock, R .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (02) :136-143
[9]   Considering the base rates of low performance in cognitively healthy older adults improves the accuracy to identify neurocognitive impairment with the Consortium to Establish a Registry for Alzheimer's Disease-Neuropsychological Assessment Battery (CERAD-NAB) [J].
Mistridis, Panagiota ;
Egli, Simone C. ;
Iverson, Grant L. ;
Berres, Manfred ;
Willmes, Klaus ;
Welsh-Bohmer, Kathleen A. ;
Monsch, Andreas U. .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2015, 265 (05) :407-417
[10]   The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment [J].
Nasreddine, ZS ;
Phillips, NA ;
Bédirian, V ;
Charbonneau, S ;
Whitehead, V ;
Collin, I ;
Cummings, JL ;
Chertkow, H .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) :695-699